Canpolat, M. Et Al. 2018. The use of rapamycin in patients with tuberous sclerosis complex: Long-term results. EPILEPSY & BEHAVIOR , vol.88 , 357-364.

Canpolat, M., Gümüş, H., Kumandaş, S., Coşkun, A., & Per, H., (2018). The use of rapamycin in patients with tuberous sclerosis complex: Long-term results. EPILEPSY & BEHAVIOR , vol.88, 357-364.

Canpolat, MEHMET Et Al. "The use of rapamycin in patients with tuberous sclerosis complex: Long-term results," EPILEPSY & BEHAVIOR , vol.88, 357-364, 2018

Canpolat, MEHMET Et Al. "The use of rapamycin in patients with tuberous sclerosis complex: Long-term results." EPILEPSY & BEHAVIOR , vol.88, pp.357-364, 2018

Canpolat, M. Et Al. (2018) . "The use of rapamycin in patients with tuberous sclerosis complex: Long-term results." EPILEPSY & BEHAVIOR , vol.88, pp.357-364.

@article{article, author={MEHMET CANPOLAT Et Al. }, title={The use of rapamycin in patients with tuberous sclerosis complex: Long-term results}, journal={EPILEPSY & BEHAVIOR}, year=2018, pages={357-364} }